Top Marijuana Stocks To Focus On In The Stock Market
Marijuana stock investors are focused on what will bring down volatility and increase momentum. For the last several years the positive news of passing some type of federal reform has created better days of trading. Now the cannabis industry as a whole is developing and evolving day by day. Currently, more than half of the United States and other countries around the world have legalized cannabis. For some companies, this has worked in their favor by expanding operations and increasing profitability.
Unfortunately for the USA cannabis is still federally illegal so volatility will continue to impact the sector. Still, even in a volatile market, there are strategies to see some upside from your investments. In an unpredictable sector like cannabis being able to adapt quickly is a skill that can have a big advantage. When there is a decline in the sector often this can be a moment to find marijuana stocks to buy.
For some time the cannabis sector has seen upward climbs in trading however they happen so fast that it makes taking profits tough. Yet, with a good game plan, a watchful eye, and some thorough due diligence making money from marijuana stocks is possible. Especially before the new year starts and various factors can determine how marijuana stocks will fair in 2023. The companies below are a few marijuana stocks to watch in the stock market today.
Marijuana Stocks To Watch In The Stock Market
The Scotts Miracle-Gro Company
The Scotts Miracle-Gro Company engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. The company operates through three segments: U.S. Consumer, Hawthorne, and Other.
In recent news, the company announced Matthew Garth as CFO. Garth brings more than 25 years of financial experience to Scotts Miracle-Gro. Matthew Garth led a full complement of functions in both corporate and operating finance. This ranged from treasury and investor relations to financial planning and analysis, among others.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. Recently the company announced the European Commission approval of SKYRIZI®. Which is for the Treatment of Moderate to Severe Active Crohn’s Disease.
[Read More] 2 Cannabis Stocks To Watch In The Stock Market
Words From The Company
“There are still many patients suffering from debilitating symptoms associated with Crohn’s disease, such as abdominal pain and stool frequency, which is why we’ve embraced the challenge of serving these patients in need,” said Thomas Hudson, M.D., senior vice president, research and development, chief scientific officer, AbbVie.